Form 8-K Intellia Therapeutics, For: Aug 08

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Form 8-K Intellia Therapeutics, For: Aug 08

Intellia Therapeutics (NTLA) PT Lowered to $54 at RBC Capital

August 9, 2024 6:27 AM EDT

RBC Capital analyst Luca Issi lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $54.00 (from $60.00) while maintaining a Outperform rating.

The analyst comments "Following Phase II study that hit primary and all secondary endpoints (to be presented in 4Q) NTLA is planning to start... More